Literature DB >> 17129293

Neurolysis of the trigeminal and sphenopalatine ganglions.

M Day1.   

Abstract

Facial pain of trigeminal and sphenopalatine ganglion origin is the bain of existence for thousands of people. Treatment protocols typically begin with oral medication, usually anticonvulsants, and may progress to percutaneous and open surgical procedures. Several new medications show promise as alternatives to carbamazepine, which has been the standard first-line treatment (trigeminal neuralgia), while electromagnetic pulsed radiofrequency and gamma knife surgery are new options when the surgical route is warranted. This article will examine the anatomy of the trigeminal and sphenopalatine ganglions. Indications for neurolysis and neurolytic options will be discussed. Efficacy of the various neurolytic techniques will be thoroughly reviewed.

Entities:  

Year:  2001        PMID: 17129293     DOI: 10.1046/j.1533-2500.2001.01018.x

Source DB:  PubMed          Journal:  Pain Pract        ISSN: 1530-7085            Impact factor:   3.183


  3 in total

Review 1.  The role of chemical neurolysis in cancer pain.

Authors:  Dhanalakshmi Koyyalagunta; Allen W Burton
Journal:  Curr Pain Headache Rep       Date:  2010-08

Review 2.  Role of sphenopalatine ganglion neuroablation in the management of cluster headache.

Authors:  Samer N Narouze
Journal:  Curr Pain Headache Rep       Date:  2010-04

3.  Evaluation of sphenopalatine ganglion blockade via intra oral route for the management of atypical trigeminal neuralgia.

Authors:  Ilker Coven; Ezher H Dayısoylu
Journal:  Springerplus       Date:  2016-06-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.